Oxybutynin Al (Oxybutynin Hydrochloride)

Oxybutynin, the active ingredient in Oxybutynin Al, is an anticholinergic presented as a tablet for oral use. It treats overactive bladder symptoms such as urgency, frequency, and incontinence in adults.

GNH USA supplies Oxybutynin Al as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxybutynin is an anticholinergic medication that acts on the urinary bladder smooth‑muscle pathway to reduce involuntary contractions. - Overactive bladder: improves bladder capacity and reduces urgency episodes. - Urinary incontinence: decreases the frequency of leak episodes. - Detrusor overactivity associated with neurological conditions: helps control bladder spasms.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Dry mouth: reduced salivation leading to a feeling of thirst. - Constipation: slowed gastrointestinal transit. - Blurred vision: temporary difficulty focusing. - Dizziness: light‑headed sensation, especially when standing. - Urinary retention: difficulty initiating or completing urination.

Serious or Rare Side Effects: - Acute angle‑closure glaucoma: sudden eye pain and visual loss. - Severe constipation or paralytic ileus: bowel obstruction symptoms. - Cardiac arrhythmias: irregular heart rhythm requiring medical attention. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Allergic reactions: rash, itching, swelling, or anaphylaxis.

Before initiating therapy, clinicians should evaluate patient history and comorbid conditions. - Assess renal function: dose adjustment may be required in severe impairment. - Review cardiovascular status: monitor for arrhythmias in patients with heart disease. - Evaluate glaucoma risk: avoid in patients with narrow‑angle glaucoma. - Consider pregnancy and lactation: use only if benefit outweighs risk. - Monitor elderly patients: increased sensitivity to anticholinergic effects. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Oxybutynin may interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid):\n- Ketamine: may potentiate anticholinergic toxicity. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): increase oxy‑hydroxy plasma levels. - Anticholinergic burden: concurrent use with other anticholinergics heightens side‑effect risk.

Moderate Interactions (Monitor Closely): - Antihistamines (diphenhydramine): additive sedation and dry‑mouth effects. - Opioids (codeine, morphine): may worsen urinary retention. - Beta‑blockers: potential for increased heart‑rate variability.